Crl:CD(SD) |
mammary tumor number |
maternal milk (for 20 days) and vehicle control condition (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days) |
Jenkins S, et al., Environ Health Perspect. 2009 Jun;117(6):910-5. doi: 10.1289/ehp.11751. Epub 2009 Jan 7. |
mammary gland integrity trait |
female |
0 days-365 days |
32 |
2.84 |
null |
0.31 |
1.75 |
manual palpation method |
0.0 |
|
0 |
|
76264 |
1558 |
COP/OlaHsd |
mammary tumor number |
17 beta-estradiol (27.5 mg) (between 212 and 330 days) |
Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30 |
mammary gland integrity trait |
female |
271 days-397 days |
20 |
0.4 |
null |
0.13 |
0.6 |
manual palpation method |
0 |
|
0 |
|
11753 |
144 |
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm |
mammary tumor number |
7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) |
Piessevaux G, et al., Mamm Genome. 2008 Dec 4 |
mammary gland integrity trait |
female |
0 days
| 46 |
7.61 |
null |
0.45 |
3.05 |
manual palpation method |
0 |
DMBA oral gavage |
133 |
days |
11356 |
74 |
BN/SsNHsd |
mammary tumor number |
17 beta-estradiol (27.5 mg) (between 196 and 199 days) |
Schaffer BS, et al., Cancer Res. 2006 Aug 1;66(15):7793-800 |
mammary gland integrity trait |
female |
259 days
| 13 |
0.0 |
null |
|
|
manual palpation method |
|
crystalline implant |
0 |
|
11381 |
81 |
Crl:CD(SD) |
mammary tumor number |
maternal milk (for 20 days) and bisphenol A (250 ug/kg) (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days) |
Jenkins S, et al., Environ Health Perspect. 2009 Jun;117(6):910-5. doi: 10.1289/ehp.11751. Epub 2009 Jan 7. |
mammary gland integrity trait |
female |
0 days-365 days |
24 |
5.0 |
null |
0.88 |
4.31 |
manual palpation method |
0.0 |
|
0 |
|
76266 |
1558 |
SPRD/Ztm |
mammary tumor number |
7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) |
Piessevaux G, et al., Mamm Genome. 2008 Dec 4 |
mammary gland integrity trait |
female |
0 days
| 17 |
10.89 |
null |
0.43 |
1.77 |
manual palpation method |
0 |
DMBA oral gavage |
133 |
days |
11354 |
74 |
SPRD.WKY-(D5Rat190-D5Rat114)(D18Rat102-D18Rat44)/Ibmm |
mammary tumor number |
7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) |
Piessevaux G, et al., Mamm Genome. 2008 Dec 4 |
mammary gland integrity trait |
female |
0 days
| 33 |
5.0 |
null |
0.44 |
2.53 |
manual palpation method |
0 |
DMBA oral gavage |
133 |
days |
11358 |
74 |
ACI/SegHsd |
mammary tumor number |
17 beta-estradiol (27.5 mg) (between 193 and 199 days) |
Schaffer BS, et al., Cancer Res. 2006 Aug 1;66(15):7793-800 |
mammary gland integrity trait |
female |
143 days-259 days |
22 |
8.8 |
null |
1.4 |
6.57 |
manual palpation method |
0.0 |
crystalline implant |
0 |
|
11382 |
81 |
SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm |
mammary tumor number |
7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) |
Piessevaux G, et al., Mamm Genome. 2008 Dec 4 |
mammary gland integrity trait |
female |
0 days
| 14 |
3.93 |
null |
0.64 |
2.39 |
manual palpation method |
0 |
DMBA oral gavage |
133 |
days |
11355 |
74 |
Crl:CD(SD) |
mammary tumor number |
maternal milk (for 20 days) and bisphenol A (25 ug/kg) (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days) |
Jenkins S, et al., Environ Health Perspect. 2009 Jun;117(6):910-5. doi: 10.1289/ehp.11751. Epub 2009 Jan 7. |
mammary gland integrity trait |
female |
0 days-365 days |
34 |
3.82 |
null |
0.43 |
2.51 |
manual palpation method |
0.0 |
|
0 |
|
76265 |
1558 |
ACI/SegHsd |
mammary tumor number |
17 beta-estradiol (27.5 mg) (between 144 and 195 days) |
Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30 |
mammary gland integrity trait |
female |
203 days-264 days |
34 |
3.9 |
null |
0.6 |
3.5 |
manual palpation method |
0 |
|
0 |
|
11752 |
144 |
SPRD.WKY-(D10Rat91-D10Rat135)/Ibmm |
mammary tumor number |
7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) |
Piessevaux G, et al., Mamm Genome. 2008 Dec 4 |
mammary gland integrity trait |
female |
0 days
| 25 |
9.24 |
null |
0.65 |
3.25 |
manual palpation method |
0 |
DMBA oral gavage |
133 |
days |
11357 |
74 |